 | • レポートコード：QFJ1-4207 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、食道がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究所）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・食道がん分子診断の市場動向 ・企業の競争状況、市場シェア ・食道がん分子診断の種類別市場規模と予測2016-2027（PCR、FISH、DNAシーケンシング、ジーンチップ） ・食道がん分子診断の用途別市場規模と予測2016-2027（臨床診断、薬物スクリーニング、研究所） ・食道がん分子診断の北米市場規模2016-2027（アメリカ、カナダ） ・食道がん分子診断の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・食道がん分子診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・食道がん分子診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・食道がん分子診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Kingmed、Geneis、Unitedgene、Yin Feng Gene、Inmedi、ApexHealth、Amoydx、Genetronhealth、Berryoncology、Topgen） ・結論 |
A molecular approach for diagnosing esophageal cancer
Market Analysis and Insights: Global Esophageal Cancer Molecular Diagnosis Market
The global Esophageal Cancer Molecular Diagnosis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Esophageal Cancer Molecular Diagnosis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Esophageal Cancer Molecular Diagnosis market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Esophageal Cancer Molecular Diagnosis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Esophageal Cancer Molecular Diagnosis market.
Global Esophageal Cancer Molecular Diagnosis Scope and Market Size
Esophageal Cancer Molecular Diagnosis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Esophageal Cancer Molecular Diagnosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
PCR
FISH
DNA Sequencing
Gene Chip
Segment by Application
Clinical Diagnosis
Drug Screening
Research
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Kingmed
Geneis
Unitedgene
Yin Feng Gene
Inmedi
ApexHealth
Amoydx
Genetronhealth
Berryoncology
Topgen
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Esophageal Cancer Molecular Diagnosis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Esophageal Cancer Molecular Diagnosis Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Esophageal Cancer Molecular Diagnosis Market Perspective (2016-2027)
2.2 Esophageal Cancer Molecular Diagnosis Growth Trends by Regions
2.2.1 Esophageal Cancer Molecular Diagnosis Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Esophageal Cancer Molecular Diagnosis Historic Market Share by Regions (2016-2021)
2.2.3 Esophageal Cancer Molecular Diagnosis Forecasted Market Size by Regions (2022-2027)
2.3 Esophageal Cancer Molecular Diagnosis Industry Dynamic
2.3.1 Esophageal Cancer Molecular Diagnosis Market Trends
2.3.2 Esophageal Cancer Molecular Diagnosis Market Drivers
2.3.3 Esophageal Cancer Molecular Diagnosis Market Challenges
2.3.4 Esophageal Cancer Molecular Diagnosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Esophageal Cancer Molecular Diagnosis Players by Revenue
3.1.1 Global Top Esophageal Cancer Molecular Diagnosis Players by Revenue (2016-2021)
3.1.2 Global Esophageal Cancer Molecular Diagnosis Revenue Market Share by Players (2016-2021)
3.2 Global Esophageal Cancer Molecular Diagnosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Esophageal Cancer Molecular Diagnosis Revenue
3.4 Global Esophageal Cancer Molecular Diagnosis Market Concentration Ratio
3.4.1 Global Esophageal Cancer Molecular Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Esophageal Cancer Molecular Diagnosis Revenue in 2020
3.5 Esophageal Cancer Molecular Diagnosis Key Players Head office and Area Served
3.6 Key Players Esophageal Cancer Molecular Diagnosis Product Solution and Service
3.7 Date of Enter into Esophageal Cancer Molecular Diagnosis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Esophageal Cancer Molecular Diagnosis Breakdown Data by Type
4.1 Global Esophageal Cancer Molecular Diagnosis Historic Market Size by Type (2016-2021)
4.2 Global Esophageal Cancer Molecular Diagnosis Forecasted Market Size by Type (2022-2027)
5 Esophageal Cancer Molecular Diagnosis Breakdown Data by Application
5.1 Global Esophageal Cancer Molecular Diagnosis Historic Market Size by Application (2016-2021)
5.2 Global Esophageal Cancer Molecular Diagnosis Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Esophageal Cancer Molecular Diagnosis Market Size (2016-2027)
6.2 North America Esophageal Cancer Molecular Diagnosis Market Size by Type
6.2.1 North America Esophageal Cancer Molecular Diagnosis Market Size by Type (2016-2021)
6.2.2 North America Esophageal Cancer Molecular Diagnosis Market Size by Type (2022-2027)
6.2.3 North America Esophageal Cancer Molecular Diagnosis Market Size by Type (2016-2027)
6.3 North America Esophageal Cancer Molecular Diagnosis Market Size by Application
6.3.1 North America Esophageal Cancer Molecular Diagnosis Market Size by Application (2016-2021)
6.3.2 North America Esophageal Cancer Molecular Diagnosis Market Size by Application (2022-2027)
6.3.3 North America Esophageal Cancer Molecular Diagnosis Market Size by Application (2016-2027)
6.4 North America Esophageal Cancer Molecular Diagnosis Market Size by Country
6.4.1 North America Esophageal Cancer Molecular Diagnosis Market Size by Country (2016-2021)
6.4.2 North America Esophageal Cancer Molecular Diagnosis Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Esophageal Cancer Molecular Diagnosis Market Size (2016-2027)
7.2 Europe Esophageal Cancer Molecular Diagnosis Market Size by Type
7.2.1 Europe Esophageal Cancer Molecular Diagnosis Market Size by Type (2016-2021)
7.2.2 Europe Esophageal Cancer Molecular Diagnosis Market Size by Type (2022-2027)
7.2.3 Europe Esophageal Cancer Molecular Diagnosis Market Size by Type (2016-2027)
7.3 Europe Esophageal Cancer Molecular Diagnosis Market Size by Application
7.3.1 Europe Esophageal Cancer Molecular Diagnosis Market Size by Application (2016-2021)
7.3.2 Europe Esophageal Cancer Molecular Diagnosis Market Size by Application (2022-2027)
7.3.3 Europe Esophageal Cancer Molecular Diagnosis Market Size by Application (2016-2027)
7.4 Europe Esophageal Cancer Molecular Diagnosis Market Size by Country
7.4.1 Europe Esophageal Cancer Molecular Diagnosis Market Size by Country (2016-2021)
7.4.2 Europe Esophageal Cancer Molecular Diagnosis Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Esophageal Cancer Molecular Diagnosis Market Size (2016-2027)
8.2 Asia-Pacific Esophageal Cancer Molecular Diagnosis Market Size by Type
8.2.1 Asia-Pacific Esophageal Cancer Molecular Diagnosis Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Esophageal Cancer Molecular Diagnosis Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Esophageal Cancer Molecular Diagnosis Market Size by Type (2016-2027)
8.3 Asia-Pacific Esophageal Cancer Molecular Diagnosis Market Size by Application
8.3.1 Asia-Pacific Esophageal Cancer Molecular Diagnosis Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Esophageal Cancer Molecular Diagnosis Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Esophageal Cancer Molecular Diagnosis Market Size by Application (2016-2027)
8.4 Asia-Pacific Esophageal Cancer Molecular Diagnosis Market Size by Region
8.4.1 Asia-Pacific Esophageal Cancer Molecular Diagnosis Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Esophageal Cancer Molecular Diagnosis Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Esophageal Cancer Molecular Diagnosis Market Size (2016-2027)
9.2 Latin America Esophageal Cancer Molecular Diagnosis Market Size by Type
9.2.1 Latin America Esophageal Cancer Molecular Diagnosis Market Size by Type (2016-2021)
9.2.2 Latin America Esophageal Cancer Molecular Diagnosis Market Size by Type (2022-2027)
9.2.3 Latin America Esophageal Cancer Molecular Diagnosis Market Size by Type (2016-2027)
9.3 Latin America Esophageal Cancer Molecular Diagnosis Market Size by Application
9.3.1 Latin America Esophageal Cancer Molecular Diagnosis Market Size by Application (2016-2021)
9.3.2 Latin America Esophageal Cancer Molecular Diagnosis Market Size by Application (2022-2027)
9.3.3 Latin America Esophageal Cancer Molecular Diagnosis Market Size by Application (2016-2027)
9.4 Latin America Esophageal Cancer Molecular Diagnosis Market Size by Country
9.4.1 Latin America Esophageal Cancer Molecular Diagnosis Market Size by Country (2016-2021)
9.4.2 Latin America Esophageal Cancer Molecular Diagnosis Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Esophageal Cancer Molecular Diagnosis Market Size (2016-2027)
10.2 Middle East & Africa Esophageal Cancer Molecular Diagnosis Market Size by Type
10.2.1 Middle East & Africa Esophageal Cancer Molecular Diagnosis Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Esophageal Cancer Molecular Diagnosis Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Esophageal Cancer Molecular Diagnosis Market Size by Type (2016-2027)
10.3 Middle East & Africa Esophageal Cancer Molecular Diagnosis Market Size by Application
10.3.1 Middle East & Africa Esophageal Cancer Molecular Diagnosis Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Esophageal Cancer Molecular Diagnosis Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Esophageal Cancer Molecular Diagnosis Market Size by Application (2016-2027)
10.4 Middle East & Africa Esophageal Cancer Molecular Diagnosis Market Size by Country
10.4.1 Middle East & Africa Esophageal Cancer Molecular Diagnosis Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Esophageal Cancer Molecular Diagnosis Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Kingmed
11.1.1 Kingmed Company Details
11.1.2 Kingmed Business Overview
11.1.3 Kingmed Esophageal Cancer Molecular Diagnosis Introduction
11.1.4 Kingmed Revenue in Esophageal Cancer Molecular Diagnosis Business (2016-2021)
11.1.5 Kingmed Recent Development
11.2 Geneis
11.2.1 Geneis Company Details
11.2.2 Geneis Business Overview
11.2.3 Geneis Esophageal Cancer Molecular Diagnosis Introduction
11.2.4 Geneis Revenue in Esophageal Cancer Molecular Diagnosis Business (2016-2021)
11.2.5 Geneis Recent Development
11.3 Unitedgene
11.3.1 Unitedgene Company Details
11.3.2 Unitedgene Business Overview
11.3.3 Unitedgene Esophageal Cancer Molecular Diagnosis Introduction
11.3.4 Unitedgene Revenue in Esophageal Cancer Molecular Diagnosis Business (2016-2021)
11.3.5 Unitedgene Recent Development
11.4 Yin Feng Gene
11.4.1 Yin Feng Gene Company Details
11.4.2 Yin Feng Gene Business Overview
11.4.3 Yin Feng Gene Esophageal Cancer Molecular Diagnosis Introduction
11.4.4 Yin Feng Gene Revenue in Esophageal Cancer Molecular Diagnosis Business (2016-2021)
11.4.5 Yin Feng Gene Recent Development
11.5 Inmedi
11.5.1 Inmedi Company Details
11.5.2 Inmedi Business Overview
11.5.3 Inmedi Esophageal Cancer Molecular Diagnosis Introduction
11.5.4 Inmedi Revenue in Esophageal Cancer Molecular Diagnosis Business (2016-2021)
11.5.5 Inmedi Recent Development
11.6 ApexHealth
11.6.1 ApexHealth Company Details
11.6.2 ApexHealth Business Overview
11.6.3 ApexHealth Esophageal Cancer Molecular Diagnosis Introduction
11.6.4 ApexHealth Revenue in Esophageal Cancer Molecular Diagnosis Business (2016-2021)
11.6.5 ApexHealth Recent Development
11.7 Amoydx
11.7.1 Amoydx Company Details
11.7.2 Amoydx Business Overview
11.7.3 Amoydx Esophageal Cancer Molecular Diagnosis Introduction
11.7.4 Amoydx Revenue in Esophageal Cancer Molecular Diagnosis Business (2016-2021)
11.7.5 Amoydx Recent Development
11.8 Genetronhealth
11.8.1 Genetronhealth Company Details
11.8.2 Genetronhealth Business Overview
11.8.3 Genetronhealth Esophageal Cancer Molecular Diagnosis Introduction
11.8.4 Genetronhealth Revenue in Esophageal Cancer Molecular Diagnosis Business (2016-2021)
11.8.5 Genetronhealth Recent Development
11.9 Berryoncology
11.9.1 Berryoncology Company Details
11.9.2 Berryoncology Business Overview
11.9.3 Berryoncology Esophageal Cancer Molecular Diagnosis Introduction
11.9.4 Berryoncology Revenue in Esophageal Cancer Molecular Diagnosis Business (2016-2021)
11.9.5 Berryoncology Recent Development
11.10 Topgen
11.10.1 Topgen Company Details
11.10.2 Topgen Business Overview
11.10.3 Topgen Esophageal Cancer Molecular Diagnosis Introduction
11.10.4 Topgen Revenue in Esophageal Cancer Molecular Diagnosis Business (2016-2021)
11.10.5 Topgen Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Esophageal Cancer Molecular Diagnosis Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of PCR
Table 3. Key Players of FISH
Table 4. Key Players of DNA Sequencing
Table 5. Key Players of Gene Chip
Table 6. Global Esophageal Cancer Molecular Diagnosis Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Esophageal Cancer Molecular Diagnosis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Esophageal Cancer Molecular Diagnosis Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Esophageal Cancer Molecular Diagnosis Market Share by Regions (2016-2021)
Table 10. Global Esophageal Cancer Molecular Diagnosis Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Esophageal Cancer Molecular Diagnosis Market Share by Regions (2022-2027)
Table 12. Esophageal Cancer Molecular Diagnosis Market Trends
Table 13. Esophageal Cancer Molecular Diagnosis Market Drivers
Table 14. Esophageal Cancer Molecular Diagnosis Market Challenges
Table 15. Esophageal Cancer Molecular Diagnosis Market Restraints
Table 16. Global Esophageal Cancer Molecular Diagnosis Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Esophageal Cancer Molecular Diagnosis Market Share by Players (2016-2021)
Table 18. Global Top Esophageal Cancer Molecular Diagnosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Esophageal Cancer Molecular Diagnosis as of 2020)
Table 19. Ranking of Global Top Esophageal Cancer Molecular Diagnosis Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Esophageal Cancer Molecular Diagnosis Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Esophageal Cancer Molecular Diagnosis Product Solution and Service
Table 23. Date of Enter into Esophageal Cancer Molecular Diagnosis Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Esophageal Cancer Molecular Diagnosis Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Esophageal Cancer Molecular Diagnosis Revenue Market Share by Type (2016-2021)
Table 27. Global Esophageal Cancer Molecular Diagnosis Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Esophageal Cancer Molecular Diagnosis Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Esophageal Cancer Molecular Diagnosis Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Esophageal Cancer Molecular Diagnosis Revenue Market Share by Application (2016-2021)
Table 31. Global Esophageal Cancer Molecular Diagnosis Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Esophageal Cancer Molecular Diagnosis Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Esophageal Cancer Molecular Diagnosis Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Esophageal Cancer Molecular Diagnosis Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Esophageal Cancer Molecular Diagnosis Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Esophageal Cancer Molecular Diagnosis Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Esophageal Cancer Molecular Diagnosis Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Esophageal Cancer Molecular Diagnosis Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Esophageal Cancer Molecular Diagnosis Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Esophageal Cancer Molecular Diagnosis Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Esophageal Cancer Molecular Diagnosis Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Esophageal Cancer Molecular Diagnosis Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Esophageal Cancer Molecular Diagnosis Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Esophageal Cancer Molecular Diagnosis Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Esophageal Cancer Molecular Diagnosis Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Esophageal Cancer Molecular Diagnosis Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Esophageal Cancer Molecular Diagnosis Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Esophageal Cancer Molecular Diagnosis Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Esophageal Cancer Molecular Diagnosis Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Esophageal Cancer Molecular Diagnosis Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Esophageal Cancer Molecular Diagnosis Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Esophageal Cancer Molecular Diagnosis Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Esophageal Cancer Molecular Diagnosis Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Esophageal Cancer Molecular Diagnosis Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Esophageal Cancer Molecular Diagnosis Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Esophageal Cancer Molecular Diagnosis Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Esophageal Cancer Molecular Diagnosis Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Esophageal Cancer Molecular Diagnosis Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Esophageal Cancer Molecular Diagnosis Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Esophageal Cancer Molecular Diagnosis Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Esophageal Cancer Molecular Diagnosis Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Esophageal Cancer Molecular Diagnosis Market Size by Country (2022-2027) & (US$ Million)
Table 63. Kingmed Company Details
Table 64. Kingmed Business Overview
Table 65. Kingmed Esophageal Cancer Molecular Diagnosis Product
Table 66. Kingmed Revenue in Esophageal Cancer Molecular Diagnosis Business (2016-2021) & (US$ Million)
Table 67. Kingmed Recent Development
Table 68. Geneis Company Details
Table 69. Geneis Business Overview
Table 70. Geneis Esophageal Cancer Molecular Diagnosis Product
Table 71. Geneis Revenue in Esophageal Cancer Molecular Diagnosis Business (2016-2021) & (US$ Million)
Table 72. Geneis Recent Development
Table 73. Unitedgene Company Details
Table 74. Unitedgene Business Overview
Table 75. Unitedgene Esophageal Cancer Molecular Diagnosis Product
Table 76. Unitedgene Revenue in Esophageal Cancer Molecular Diagnosis Business (2016-2021) & (US$ Million)
Table 77. Unitedgene Recent Development
Table 78. Yin Feng Gene Company Details
Table 79. Yin Feng Gene Business Overview
Table 80. Yin Feng Gene Esophageal Cancer Molecular Diagnosis Product
Table 81. Yin Feng Gene Revenue in Esophageal Cancer Molecular Diagnosis Business (2016-2021) & (US$ Million)
Table 82. Yin Feng Gene Recent Development
Table 83. Inmedi Company Details
Table 84. Inmedi Business Overview
Table 85. Inmedi Esophageal Cancer Molecular Diagnosis Product
Table 86. Inmedi Revenue in Esophageal Cancer Molecular Diagnosis Business (2016-2021) & (US$ Million)
Table 87. Inmedi Recent Development
Table 88. ApexHealth Company Details
Table 89. ApexHealth Business Overview
Table 90. ApexHealth Esophageal Cancer Molecular Diagnosis Product
Table 91. ApexHealth Revenue in Esophageal Cancer Molecular Diagnosis Business (2016-2021) & (US$ Million)
Table 92. ApexHealth Recent Development
Table 93. Amoydx Company Details
Table 94. Amoydx Business Overview
Table 95. Amoydx Esophageal Cancer Molecular Diagnosis Product
Table 96. Amoydx Revenue in Esophageal Cancer Molecular Diagnosis Business (2016-2021) & (US$ Million)
Table 97. Amoydx Recent Development
Table 98. Genetronhealth Company Details
Table 99. Genetronhealth Business Overview
Table 100. Genetronhealth Revenue in Esophageal Cancer Molecular Diagnosis Business (2016-2021) & (US$ Million)
Table 101. Genetronhealth Recent Development
Table 102. Berryoncology Company Details
Table 103. Berryoncology Business Overview
Table 104. Berryoncology Esophageal Cancer Molecular Diagnosis Product
Table 105. Berryoncology Revenue in Esophageal Cancer Molecular Diagnosis Business (2016-2021) & (US$ Million)
Table 106. Berryoncology Recent Development
Table 107. Topgen Company Details
Table 108. Topgen Business Overview
Table 109. Topgen Esophageal Cancer Molecular Diagnosis Product
Table 110. Topgen Revenue in Esophageal Cancer Molecular Diagnosis Business (2016-2021) & (US$ Million)
Table 111. Topgen Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Esophageal Cancer Molecular Diagnosis Market Share by Type: 2020 VS 2027
Figure 2. PCR Features
Figure 3. FISH Features
Figure 4. DNA Sequencing Features
Figure 5. Gene Chip Features
Figure 6. Global Esophageal Cancer Molecular Diagnosis Market Share by Application: 2020 VS 2027
Figure 7. Clinical Diagnosis Case Studies
Figure 8. Drug Screening Case Studies
Figure 9. Research Case Studies
Figure 10. Esophageal Cancer Molecular Diagnosis Report Years Considered
Figure 11. Global Esophageal Cancer Molecular Diagnosis Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Esophageal Cancer Molecular Diagnosis Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Esophageal Cancer Molecular Diagnosis Market Share by Regions: 2020 VS 2027
Figure 14. Global Esophageal Cancer Molecular Diagnosis Market Share by Regions (2022-2027)
Figure 15. Global Esophageal Cancer Molecular Diagnosis Market Share by Players in 2020
Figure 16. Global Top Esophageal Cancer Molecular Diagnosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Esophageal Cancer Molecular Diagnosis as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Esophageal Cancer Molecular Diagnosis Revenue in 2020
Figure 18. Global Esophageal Cancer Molecular Diagnosis Revenue Market Share by Type (2016-2021)
Figure 19. Global Esophageal Cancer Molecular Diagnosis Revenue Market Share by Type (2022-2027)
Figure 20. North America Esophageal Cancer Molecular Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Esophageal Cancer Molecular Diagnosis Market Share by Type (2016-2027)
Figure 22. North America Esophageal Cancer Molecular Diagnosis Market Share by Application (2016-2027)
Figure 23. North America Esophageal Cancer Molecular Diagnosis Market Share by Country (2016-2027)
Figure 24. United States Esophageal Cancer Molecular Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Esophageal Cancer Molecular Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Esophageal Cancer Molecular Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Esophageal Cancer Molecular Diagnosis Market Share by Type (2016-2027)
Figure 28. Europe Esophageal Cancer Molecular Diagnosis Market Share by Application (2016-2027)
Figure 29. Europe Esophageal Cancer Molecular Diagnosis Market Share by Country (2016-2027)
Figure 30. Germany Esophageal Cancer Molecular Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Esophageal Cancer Molecular Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Esophageal Cancer Molecular Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Esophageal Cancer Molecular Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Esophageal Cancer Molecular Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Esophageal Cancer Molecular Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Esophageal Cancer Molecular Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Esophageal Cancer Molecular Diagnosis Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Esophageal Cancer Molecular Diagnosis Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Esophageal Cancer Molecular Diagnosis Market Share by Region (2016-2027)
Figure 40. China Esophageal Cancer Molecular Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Esophageal Cancer Molecular Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Esophageal Cancer Molecular Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Esophageal Cancer Molecular Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Esophageal Cancer Molecular Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Esophageal Cancer Molecular Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Esophageal Cancer Molecular Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Esophageal Cancer Molecular Diagnosis Market Share by Type (2016-2027)
Figure 48. Latin America Esophageal Cancer Molecular Diagnosis Market Share by Application (2016-2027)
Figure 49. Latin America Esophageal Cancer Molecular Diagnosis Market Share by Country (2016-2027)
Figure 50. Mexico Esophageal Cancer Molecular Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Esophageal Cancer Molecular Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Esophageal Cancer Molecular Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Esophageal Cancer Molecular Diagnosis Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Esophageal Cancer Molecular Diagnosis Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Esophageal Cancer Molecular Diagnosis Market Share by Country (2016-2027)
Figure 56. Turkey Esophageal Cancer Molecular Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Esophageal Cancer Molecular Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Esophageal Cancer Molecular Diagnosis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Kingmed Revenue Growth Rate in Esophageal Cancer Molecular Diagnosis Business (2016-2021)
Figure 60. Geneis Revenue Growth Rate in Esophageal Cancer Molecular Diagnosis Business (2016-2021)
Figure 61. Unitedgene Revenue Growth Rate in Esophageal Cancer Molecular Diagnosis Business (2016-2021)
Figure 62. Yin Feng Gene Revenue Growth Rate in Esophageal Cancer Molecular Diagnosis Business (2016-2021)
Figure 63. Inmedi Revenue Growth Rate in Esophageal Cancer Molecular Diagnosis Business (2016-2021)
Figure 64. ApexHealth Revenue Growth Rate in Esophageal Cancer Molecular Diagnosis Business (2016-2021)
Figure 65. Amoydx Revenue Growth Rate in Esophageal Cancer Molecular Diagnosis Business (2016-2021)
Figure 66. Genetronhealth Revenue Growth Rate in Esophageal Cancer Molecular Diagnosis Business (2016-2021)
Figure 67. Berryoncology Revenue Growth Rate in Esophageal Cancer Molecular Diagnosis Business (2016-2021)
Figure 68. Topgen Revenue Growth Rate in Esophageal Cancer Molecular Diagnosis Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
世界の口腔がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing oral cancer Market Analysis and Insights: Global Oral Cancer Molecular Diagnosis Market The global Oral Cancer Molecular Diagnosis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With indust…- 世界の胆嚢がん分子診断市場規模・現状・予測（2021年-2027年） A method for diagnosing gallbladder cancer Market Analysis and Insights: Global Molecular Diagnosis of Gallbladder Cancer Market The global Molecular Diagnosis of Gallbladder Cancer market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-20…
- 世界の遺伝性大腸がん分子診断市場規模・現状・予測（2021年-2027年） A method for diagnosing hereditary colorectal cancer Market Analysis and Insights: Global Molecular Diagnosis of Hereditary Colorectal Cancer Market The global Molecular Diagnosis of Hereditary Colorectal Cancer market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, a…
- 世界の精巣がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing testicular Cancer Market Analysis and Insights: Global Molecular Diagnosis of Testicular Cancer Market The global Molecular Diagnosis of Testicular Cancer market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% durin…
- 世界の直腸がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing rectal cancer Market Analysis and Insights: Global Molecular Diagnosis of Rectal Cancer Market The global Molecular Diagnosis of Rectal Cancer market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.…